Lars Ittner

View Scopus Profile

Lars Ittner

Director, Dementia Research Centre, Professor

 https://orcid.org/0000-0001-6738-3825
Calculated based on number of publications stored in Pure and citations from Scopus
20022024

Research activity per year

Filter
Patent

Search results

  • 2024

    Inhibitors and uses therefor

    Ittner, L. M., Ariawan, D., Tietz, O. & Van Eersel, J., 8 Feb 2024, IPC No. C07D 471/04 A I, A61K 31/4545 2006.1, A61K 31/517 2006.1, A61P 31/14 2006.1, C07D 401/14 2006.1, C07D 409/14 2006.1, Patent No. WO2024026540, Priority date 5 Aug 2022, Priority No. AU20220902202

    Research output: Patent

    Open Access
  • 2023

    Use of phosphorylated tau and p38gamma to treat a neurological condition

    Ittner, L. M. & Ittner, A. A., 16 Feb 2023, IPC No. A61P 25/ 28 A I, A61K 38/45, Patent No. US2023053214, Priority date 12 Sept 2022, Priority No. US202217931229

    Research output: Patent

    Open Access
  • 2022

    Compositions and methods for treatment

    Ittner, L. & Ke, Y. D., 3 Nov 2022, IPC No. A61P 25/ 28 A I, A61K 38/08, Patent No. US2022347258, 12 Aug 2020, Priority date 12 Aug 2019, Priority No. AU2019902892

    Research output: Patent

    Open Access

  • Compositions and methods for treatment

    Ittner, L. & Ke, Y. D., 3 Mar 2022, IPC No. C07K 14/ 47 A I, A61K 38/00, A61P 25/28, Patent No. AU2020331401, 12 Aug 2020, Priority date 12 Aug 2020, Priority No. WO2020AU50833

    Research output: Patent

    Open Access

  • Compositions and methods for treatment

    Ittner, L. & Ke, Y. D., 22 Jun 2022, IPC No. C07K 14/ 47 A I, A61K 38/00, A61P 25/28, Patent No. EP4013773, Priority date 12 Aug 2019, Priority No. AU2019902892

    Research output: Patent

    Open Access

  • Treatment of dementia

    Ittner, L. & Ke, Y. D., 19 May 2022, (Submitted) IPC No. A61P 25/ 28 A I, A61K 31/519, Patent No. AU2020351830, 25 Sept 2020, Priority date 25 Sept 2020, Priority No. WO2020AU51022

    Research output: Patent

  • Treatment of dementia

    Ittner, L. & Ke, Y. D., 15 Sept 2022, (Submitted) IPC No. A61P 25/ 28 A I, A61K 31/519, Patent No. US2022288082, Priority date 25 Sept 2020, Priority No. WO2020AU51022

    Research output: Patent

  • Treatment of dementia

    Ittner, L. & Ke, Y. D., 3 Aug 2022, (Submitted) IPC No. A61P 25/ 28 A I, A61K31/519, Patent No. EP4034124, 25 Sept 2020, Priority date 25 Sept 2020, Priority No. WO2020AU51022

    Research output: Patent

  • Treatment of excitotoxicity-related conditions

    Ittner, L. & Ke, Y. D., 3 Aug 2022, IPC No. A61P 25/ 08 A I, A61K 31/519, A61P 25/00, A61K 45/06, A61P 9/10, A61P 27/06, Patent No. EP4034125, Priority date 25 Sept 2019, Priority No. AU2019903588

    Research output: Patent

    Open Access

  • Treatment of excitotoxicity-related conditions

    Ittner, L. & Ke, Y. D., 15 Sept 2022, IPC No. A61P 25/ 08 A I, A61K 31/519, Patent No. US2022288081, 25 Sept 2020, Priority date 25 Sept 2019, Priority No. AU2019903588

    Research output: Patent

    Open Access

  • Treatment of excitotoxicity-related conditions

    Ittner, L. & Ke, Y. D., 19 May 2022, IPC No. A61P 25/ 08 A I, A61K 31/519, A61P 25/00, Patent No. AU2020354786, 25 Sept 2020, Priority date 25 Sept 2020, Priority No. AU2019903588

    Research output: Patent

    Open Access

  • Treatment of tauopathies

    Ittner, L. & Ittner, A., 10 Mar 2022, IPC No. C12N 15/ 11 A I, A61P 25/28, A61K 31/7105, A61K 38/45, Patent No. AU2020353719, 23 Sept 2020, Priority date 23 Sept 2019, Priority No. AU2019903530

    Research output: Patent

    Open Access

  • Treatment of tauopathies

    Ittner, L. & Ittner, A., 3 Aug 2022, IPC No. C12N 15/ 11 A I, A61P 25/28, A01K 67/027, A61K 31/7105, A61K 38/45, A61K 48/00, Patent No. EP4034240, Priority date 23 Sept 2019, Priority No. AU2019903530

    Research output: Patent

    Open Access

  • Treatment of tauopathies

    Ittner, L. & Ittner, A., 27 Oct 2022, IPC No. C07K 14/ 47 A I, A61K 31/713, A61K 39/395, A61K 47/64, A61K 9/28, A61P 25/28, Patent No. US2022339183, Priority date 23 Sept 2019, Priority No. AU2019903530

    Research output: Patent

    Open Access
  • 2021

    Compositions and methods for treatment

    Ittner, L. & Ke, Y. D., 18 Feb 2021, IPC No. C07K 14/ 47 A I, A61K 38/00 2006.1, A61P 25/28 2006.1, Patent No. WO2021026601, 12 Aug 2020, Priority date 1 Jun 2020, Priority No. AU20200901796

    Research output: Patent

    Open Access

  • Compositions and methods for treatment

    Ittner, L. & Ke, Y. D., 18 Feb 2021, IPC No. C07K 14/ 47 A I, A61K 38/00, A61P 25/28, Patent No. CA3150627, Priority date 12 Aug 2019, Priority No. AU2019902892

    Research output: Patent

    Open Access

  • Treatment of dementia

    Ittner, L. & Ke, Y. D., 1 Apr 2021, (Submitted) IPC No. A61P 25/ 28 A I, A61K 31/519, Patent No. WO2021056071, Priority date 25 Sept 2019, Priority No. AU20190903587

    Research output: Patent

  • Treatment of excitotoxicity-related conditions

    Ittner, L. & Ke, Y. D., 1 Apr 2021, IPC No. A61P 25/ 08 A I, A61K 31/519 2006.1, A61P 25/00 2006.1, Patent No. WO2021056072, 25 Sept 2020, Priority date 25 Sept 2019, Priority No. AU20190903588

    Research output: Patent

    Open Access

  • Treatment of tauopathies

    Ittner, L. & Ittner, A., 1 Apr 2021, IPC No. C12N 15/ 11 A I, A61P 25/28 2006.1, A61K 38/45 2006.1, A61K 31/7105 2006.1, Patent No. WO2021056064, 23 Sept 2020, Priority date 23 Sept 2019, Priority No. AU20190903530

    Research output: Patent

    Open Access

  • Treatment of tauopathies

    Ittner, L. & Ittner, A., 1 Apr 2021, IPC No. C12N 15/ 11 A I, A61K 31/7105, A61K 38/45, A61P 25/28, Patent No. CA3152239, Priority date 23 Sept 2019, Priority No. AU2019903530

    Research output: Patent

    Open Access
  • 2020

    Assay and method for identifying compounds that reduce SIL1 expression or activity

    Ittner, L. & Van Eersel, J., 28 Apr 2020, IPC No. G01N 33/68, C12Q 1/6883, Patent No. 10634688, 6 Mar 2014, Priority date 6 Mar 2013, Priority No. AU2013900812

    Research output: Patent

  • 2019

    Cell culture substrates

    Martin, A., Ittner, L. M. & Ke, Y. D., 21 Feb 2019, (Submitted) IPC No. C07K 5/10 2006.01, Patent No. WO2019033171, 16 Aug 2018, Priority date 16 Aug 2017, Priority No. AU2017903293

    Research output: Patent

  • Use of phosphorylated tau and p38gamma to treat a neurological condition

    Ittner, L. M. & Ittner, A. A., 26 Dec 2019, (Submitted) IPC No. A61P 25/ 28 A I, A61K 38/45, Patent No. US20190388519, Priority date 1 Mar 2016, Priority No. AU2016900764

    Research output: Patent

  • Use of phosphorylated tau and p38gamma to treat a neurological condition

    Ittner, L. M. & Ittner, A. A., 9 Jan 2019, (Submitted) IPC No. A61P 25/28, A61K 38/17, A61K 38/45, A61P 9/10, A61P 25/08, Patent No. EP3423080, Priority date 1 Mar 2016, Priority No. AU2016900764

    Research output: Patent

  • 2018

    Cell culture substrates

    Martin, A., Ittner, L. & Ke, Y. D., 2018, (Submitted) Patent No. 2017903293, 16 Aug 2017

    Research output: Patent

  • 2017

    Use of phosphorylated tau and p38gamma to treat a neurological condition

    Ittner, L. M. & Ittner, A. A., 8 Sept 2017, (Submitted) IPC No. A61P 25/28, A61K 38/17, A61P 9/10, A61P 25/08, Patent No. AU2017225907, 1 Mar 2017, Priority date 1 Mar 2017, Priority No. AU2016900764

    Research output: Patent

  • 2016

    Assay and method for identifying compounds to treat tauopathies

    Ittner, L. M. & Van Eersel, J., 13 Jan 2016, IPC No. G01N 33/ 68 A I, C12Q 1/68, Patent No. EP2965091, Priority date 6 Mar 2013, Priority No. AU2013900812

    Research output: Patent

    Open Access

  • Assay and method for identifying compounds to treat tauopathies

    Ittner, L. M. & Van Eersel, J., 21 Jan 2016, IPC No. G01N 33/ 68 A I, C12Q 1/6883, Patent No. US2016018417, Priority date 6 Mar 2013, Priority No. AU2013900812

    Research output: Patent

    Open Access
  • 2015

    Assay and method for identifying compounds to treat tauopathies

    Ittner, L. M. & Van Eersel, J., 15 Oct 2015, IPC No. G01N 33/ 68 A I, Patent No. AU2014225301, 6 Mar 2014, Priority date 6 Mar 2013, Priority No. AU2013900812

    Research output: Patent

    Open Access